E. Kontopodis

发表

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC

V. Georgoulias, I. Varthalitis, A. Pallis, 2011, Cancer Chemotherapy and Pharmacology.

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

V. Georgoulias, G. Samonis, N. Ziras, 2011, Cancer Chemotherapy and Pharmacology.

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status.

D. Mavroudis, V. Georgoulias, E. Stathopoulos, 2010, Lung cancer.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2009, British Journal of Cancer.

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab

D. Mavroudis, V. Georgoulias, A. Kalykaki, 2011, Cancer Chemotherapy and Pharmacology.

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

S. Agelaki, V. Georgoulias, K. Syrigos, 2010, BMC Cancer.

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer

S. Agelaki, D. Mavroudis, V. Georgoulias, 2011, Cancer Chemotherapy and Pharmacology.

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .

A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer

S. Agelaki, V. Georgoulias, E. Papadimitraki, 2013, Cancer Chemotherapy and Pharmacology.